Management of atrial fibrillation.
Atrial fibrillation (AF) is a condition of genuine clinical concern. This arrhythmia increases patient morbidity and mortality, most notably due to stroke, thromboembolism and heart failure. Consequentially, there is a strong impetus to acquire a greater understanding of its natural history and course in order to provide crucial evidence-based treatment and resource allocation in the future. The objective of this review article is to present a concise overview of the management of AF, with reference to the recent evidence-based National Institute of Clinical Excellence (NICE) National Clinical Guidelines for the management of AF.
Kakar
Puneet
P
Hemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.
Boos
Christopher J
CJ
Lip
Gregory Y H
GY
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000628:therapy*; D004554:Electric Countershock / Q000379:methods*; D019317:Evidence-Based Medicine / Q000379:methods*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D005343:Fibrinolytic Agents